LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 95 of 166
Next
>>
>
2351 to 2375 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	Vemurafenib	3.33	uM	LJP5	72	hr	1334	3595	4033	0.8903	0.8569
BT-20	Vemurafenib	10	uM	LJP5	72	hr	1334	2765	4033	0.6852	0.5770
BT-20	Enzastaurin	0.04	uM	LJP5	72	hr	1334	3740	4033	0.9259	0.9018
BT-20	Enzastaurin	0.12	uM	LJP5	72	hr	1334	3928	4033	0.9734	0.9652
BT-20	Enzastaurin	0.37	uM	LJP5	72	hr	1334	4117	4033	1.0197	1.0216
BT-20	Enzastaurin	1.11	uM	LJP5	72	hr	1334	4113	4033	1.0191	1.0221
BT-20	Enzastaurin	3.33	uM	LJP5	72	hr	1334	4320	4033	1.0706	1.0862
BT-20	Enzastaurin	10	uM	LJP5	72	hr	1334	4675	4033	1.1588	1.1931
BT-20	Palbociclib	0.04	uM	LJP6	72	hr	1334	3045	3925	0.7764	0.6945
BT-20	Palbociclib	0.12	uM	LJP6	72	hr	1334	2967	3925	0.7567	0.6668
BT-20	Palbociclib	0.37	uM	LJP6	72	hr	1334	2657	3925	0.6777	0.5517
BT-20	Palbociclib	1.11	uM	LJP6	72	hr	1334	2205	3925	0.5622	0.3789
BT-20	Palbociclib	3.33	uM	LJP6	72	hr	1334	2133	3925	0.5440	0.3489
BT-20	Palbociclib	10	uM	LJP6	72	hr	1334	1679	3925	0.4281	0.1589
BT-20	PF562271	0.04	uM	LJP6	72	hr	1334	3725	3925	0.9490	0.9339
BT-20	PF562271	0.12	uM	LJP6	72	hr	1334	3540	3925	0.9019	0.8706
BT-20	PF562271	0.37	uM	LJP6	72	hr	1334	3599	3925	0.9174	0.8915
BT-20	PF562271	1.11	uM	LJP6	72	hr	1334	3147	3925	0.8019	0.7346
BT-20	PF562271	3.33	uM	LJP6	72	hr	1334	2176	3925	0.5546	0.3684
BT-20	PF562271	10	uM	LJP6	72	hr	1334	812	3925	0.2069	-0.2739
BT-20	PHA-793887	0.04	uM	LJP6	72	hr	1334	2521	3925	0.6425	0.5023
BT-20	PHA-793887	0.12	uM	LJP6	72	hr	1334	2488	3925	0.6344	0.4897
BT-20	PHA-793887	0.37	uM	LJP6	72	hr	1334	2188	3925	0.5582	0.3695
BT-20	PHA-793887	1.11	uM	LJP6	72	hr	1334	1841	3925	0.4696	0.2239
BT-20	PHA-793887	3.33	uM	LJP6	72	hr	1334	1478	3925	0.3771	0.0609

|<
<<
Previous
Page 95 of 166
Next
>>
>
2351 to 2375 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)